20.648 articles found

497. THE EFFECTIVENESS OF VAGUS NERVE STIMULATION IN THE TREATMENT OF ALZHEIMER’S AND PARKINSON’S DISEASE: A SYSTEMATIC REVIEW

Check source for author details

The international journal of neuropsychopharmacology · 2025-08-01

Therapeutic potential and challenges of mesenchymal stem cells in neurological disorders: A concise analysis.

Issa EHB, Alghazo EM, Gharaibeh R, Momani NB, Taha DZ, Jaradat RJ, Alzu'bi A, Almahasneh FA, Abu-El-Rub E, Al-Zoubi RM.

J Neuropathol Exp Neurol · 2025-08-01

DOI: 10.1093/jnen/nlaf021PMID: 40152120

Focused ultrasound therapy for movement disorders.

Martínez-Fernández R, Paschen S, Del Álamo M, Rodríguez-Rojas R, Pineda-Pardo JA, Blesa J, Kaplitt MG, Deuschl G, Obeso JA.

Lancet Neurol · 2025-08-01

DOI: 10.1016/s1474-4422(25)00210-8PMID: 40683278

Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.

Ferreira JJ, Lee JY, Ma HI, Jeon B, Poewe W, Antonini A, Stocchi F, Rodrigues DM, Fonseca MM, Castilla-Fernández G, Holenz J, Rocha JF, Rascol O, ADOPTION study investigators.

J Neurol · 2025-08-01

DOI: 10.1007/s00415-025-13122-zPMID: 40748463

The Beneficial Effects of Berberine on Brain Functions in Age-Related Neurological Disorders: From Molecular Signaling to Treatment.

Wang X, Hou R, Chen Z, Wang X, Malek M, Wang H.

Food Sci Nutr · 2025-08-01

DOI: 10.1002/fsn3.70563PMID: 40755499

Identifying Risk Factors and Constructing Predictive Models for Wearing-Off and Dyskinesia in Chinese Patients With Parkinson's Disease on Long-Term Levodopa Therapy.

Zhao J, Gao Y, Shi C, Chen J, Wang Y, Chen J, Ma S, Wang P, Li J, Du J, Wan Z.

CNS Neurosci Ther · 2025-08-01

DOI: 10.1111/cns.70544PMID: 40785408

Differential Roles of Angiotensin A and Alamandine in Parkinson's Disease: A Therapeutic Perspective on Nonclassical RAS Pathways.

Alshehri GH, Al-Kuraishy HM, Albuhadily AK, Al-Gareeb AI, Aboutaleb AS, Alexiou A, Papadakis M, Batiha GE.

Brain Behav · 2025-08-01

DOI: 10.1002/brb3.70721PMID: 40791030

Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.

Aktaş E, Hanağası HA, Özgentürk NÖ.

CNS Neurosci Ther · 2025-08-01

DOI: 10.1111/cns.70540PMID: 40808332

Scrambler Therapy for the Treatment of Chronic Neuropathic Pain in Atypical Parkinsonian Disorders: A Case Series.

Yang CY, Schmidt M, Smith TJ, Pantelyat A.

Pain Med Case Rep · 2025-08-01

PMID: 40900454

Analysis of the therapeutic potential of astragalin: insights into target interactions and mechanisms.

Duc Nguyen H.

Xenobiotica · 2025-08-01

DOI: 10.1080/00498254.2025.2559962PMID: 40934094

Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases.

Cui CX, Shao XN, Li YY, Qiao L, Lin JT, Guan LH.

World J Stem Cells · 2025-08-01

DOI: 10.4252/wjsc.v17.i8.107717PMID: 40951709

Exploring availability of physiotherapy service for people with Parkinson's Disease in Europe: An cross-sectional study.

Smilowska K, Domingos J, Carvalho V, Siuda A, Dean J, Capato T, Bloem BR.

Clin Rehabil · 2025-08-01

DOI: 10.1177/02692155251361915PMID: 40746233